Showing 1 - 6 results of 6 for search 'Koichiro Furuta', query time: 0.03s
Refine Results
-
1
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after... by Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hideki Fujii, Toru Ishii, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Shinichiro Nakamura, Namiki Izumi
Published 2022-07-01
Article -
2
A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infect... by Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Shinichiro Nakamura, Namiki Izumi
Published 2022-01-01
Article -
3
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study by Yutaka Yasui, Masayuki Kurosaki, Kaoru Tsuchiya, Yuka Hayakawa, Chitomi Hasebe, Masami Abe, Chikara Ogawa, Kouji Joko, Hironori Ochi, Toshifumi Tada, Shinichiro Nakamura, Koichiro Furuta, Hiroyuki Kimura, Keiji Tsuji, Yuji Kojima, Takehiro Akahane, Takashi Tamada, Yasushi Uchida, Masahiko Kondo, Akeri Mitsuda, Namiki Izumi
Published 2022-06-01
Article -
4
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus by Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Rohit Loomba, Namiki Izumi
Published 2022-03-01
Article -
5
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response by Shun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Toshie Mashiba, Hironori Ochi, Yutaka Yasui, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hideki Fujii, Toru Ishii, Hiroyuki Marusawa, Masahiko Kondo, Atsunori Kusakabe, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Akari Mitsuda, Chikara Ogawa, Hirotaka Arai, Toshimitsu Murohisa, Minoru Uebayashi, Namiki Izumi
Published 2023-06-01
Article -
6
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study by Kaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, Hiroyuki Marusawa, Yuji Kojima, Chitomi Hasebe, Hirotaka Arai, Kouji Joko, Masahiko Kondo, Keiji Tsuji, Tetsuro Sohda, Hiroyuki Kimura, Chikara Ogawa, Yasushi Uchida, Shuichi Wada, Haruhiko Kobashi, Koichiro Furuta, Masaya Shigeno, Atsunori Kusakabe, Takehiro Akahane, Ryoichi Narita, Hideo Yoshida, Akeri Mitsuda, Yasushi Ide, Tomomichi Matsushita, Namiki Izumi, on behalf of Japanese Red Cross Liver Study Group
Published 2021-05-01
Article